Heard; Jean-Michel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Heard; Jean-Michel.The latest application filed is for "animal model of neurodegenerative diseases, the procedure for producing the model and applications thereof".

Company Profile

0.2.7

Heard; Jean-Michel - Paris FR
Heard, Jean Michel - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Animal model of neurodegenerative diseases, the procedure for producing the model and applications thereof App 20080038227 - Torres Aleman; Ignacio ; et al.	2008-02-14
Non-human animal alzheimer's disease model and uses thereof App 20070266450 - Torres-Aleman; Ignacio ; et al.	2007-11-15
Vector for expressing alpha-N-acetyl-galactosaminidase and method of treating MPS I by stereotactic injection into the brain of a mammal App 20060182717 - Desmaris; Nathalie ; et al.	2006-08-17
Vector for expressing .alpha.-L-iduronidase and method of treating MPS I by stereotactic injection into the brain of a mammal Grant 7,090,836 - Desmaris , et al. August 15, 2	2006-08-15
Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro App 20040236093 - Schwartz, Olivier ; et al.	2004-11-25
Purified nucleic acid molecule for the expression of a lysosomal enzyme and use thereof for preventing or treating lysosomal storage diseases App 20040023218 - Desmaris, Nathalie ; et al.	2004-02-05
MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Application to the stimulation of CTL and vaccination in vivo; analysis of vaccinating composition in vitro App 20020172683 - Schwartz, Olivier ; et al.	2002-11-21
Biocompatible implant for the expression and in vivo secretion of a therapeutic substance App 20020098223 - Moullier, Philippe ; et al.	2002-07-25
Biocompatible implant for the expression and in vivo secretion of a therapeutic substance Grant 5,906,817 - Moullier , et al. May 25, 1	1999-05-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.